Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,581 total articles

Xometry After the Rally - Why I'm Still Buying and Where I Draw the Line

Xometry After the Rally - Why I'm Still Buying and Where I Draw the Line

Xometry's AI-driven industrial marketplace has ripped higher, but the fundamental picture still supports more upside: accelerating revenue, improving profitability signals, a successful $225M equity raise at $85, and a materially reduced short interest backdrop. This trade idea lays out an exact entry, stop, and target, the time horizon for the tra…

SmartRent at the Bargain Bin: Tactical Long After a Downgrade

SmartRent at the Bargain Bin: Tactical Long After a Downgrade

SmartRent (SMRT) looks unusually cheap on headline metrics - market cap near $220M, EV roughly $119M and EV/Sales ~0.8 - but the stock still carries execution, cash-flow and legal overhangs. We lower the rating on fundamentals and governance risk, yet present a tactical swing trade: a small, structured long at $1.14 with a tight stop and a target n…

Buy Alphabet on Cloud Momentum and AI Capex Optionality

Buy Alphabet on Cloud Momentum and AI Capex Optionality

Alphabet ($GOOG) is a conviction long over the next 180 trading days. Google Cloud’s stronger-than-expected commercial traction, combined with Alphabet’s $64.4B free cash flow and low leverage, supports further AI infrastructure investment that can re-accelerate revenue and margins. Enter near $368.00, stop $346.00, target $405.00.

New Found Gold: Buy the Pullback — High-Grade Asset, Reasonable Valuation, Weathering Stable Gold Prices

New Found Gold: Buy the Pullback — High-Grade Asset, Reasonable Valuation, Weathering Stable Gold Prices

New Found Gold (NFGC) is a development-stage gold producer sitting on high-grade Newfoundland assets. At a market cap near $568M, the stock is priced for execution rather than speculation. Technicals show a short-term oversold tone while fundamentals — recent drill success and rising industry M&A — support upside if management continues to advance …

How to Get in Early on Sivers Semiconductors: A 180-Day Trade Plan

How to Get in Early on Sivers Semiconductors: A 180-Day Trade Plan

Sivers Semiconductors (SIVR) is an underfollowed RF and mmWave component specialist positioned to benefit from a renewed 5G infrastructure refresh and edge connectivity builds. This trade idea lays out a precise entry at $2.40, a protective stop at $1.60 and a $4.20 target over a 180 trading day horizon, with clear catalysts and risks.

KBR: Hidden SOTP Upside — Buy the Re-rate in Defense + Sustainability

KBR: Hidden SOTP Upside — Buy the Re-rate in Defense + Sustainability

KBR trades at ~10x 2026 EPS with $489M in free cash flow and a $6.36B enterprise value that looks cheap relative to the optionality in its Mission Technology and Sustainable Technology franchises. A disciplined entry around current levels with a tight stop and a 180-trading-day target captures both contract ramp and a potential re-rating tied to co…

XDEMVY Is Carrying Tarsus — Pay Up, But Don’t Pay Blindly

XDEMVY Is Carrying Tarsus — Pay Up, But Don’t Pay Blindly

Tarsus has turned its FDA approval into real revenue: XDEMVY generated strong top-line growth and margin leverage in early 2026. The stock is not cheap on traditional multiples, but guidance for $670-700M in XDEMVY sales for 2026 narrows the gap between price and prospective value. This trade idea buys the story on continued execution while protect…

Buy the Rumor, Trade the Noise - A Tactical Long on Lionsgate

Buy the Rumor, Trade the Noise - A Tactical Long on Lionsgate

Lionsgate is once again in the headlines after M&A speculation and public denials created a volatility window. This is a tactical, event-driven long: enter at $6.50, stop at $4.75, with a primary target of $10.00 on a mid-term timeline (45 trading days). The trade bets that continued deal flow or asset-sale chatter will re-rate the stock before the…

Buy the Panic: Why Accenture's Plunge Looks Like an Overreaction

Buy the Panic: Why Accenture's Plunge Looks Like an Overreaction

Accenture (ACN) dropped into the low $120s after softer-than-expected revenue guidance and a heavy M&A cadence. Fundamentals - free cash flow, low net leverage, and a double-digit yield on cash flow - argue the sell-off is a stretched reaction. This trade idea outlines a long entry at $128.29, a conservative stop at $105, and a $220 target over 180…

Spero's Utebzi Approval: Why Yesterday's Dump Feels Like an Overreaction

Spero's Utebzi Approval: Why Yesterday's Dump Feels Like an Overreaction

Spero Therapeutics (SPRO) fell sharply after the FDA approval announcement for Utebzi (tebipenem pivoxil HBr) on 06/17/2026. The approval is a clear commercial milestone: the first oral carbapenem for complicated UTIs. With a market cap of roughly $132M, an enterprise value of ~$66M, and reported EPS near $0.26, the selloff looks disconnected from …